ABVC BioPharma, Inc.
ABVC
$2.41
-$0.12-4.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -215.73% | -139.52% | 70.29% | 159.82% | 88.10% |
| Total Depreciation and Amortization | -9.77% | -29.31% | 11.12% | -50.11% | 1,318.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 312.42% | 272.77% | -90.18% | -1,064.21% | -85.38% |
| Change in Net Operating Assets | -348.74% | -309.81% | 94.30% | 53.78% | 3,433.33% |
| Cash from Operations | -321.43% | -322.99% | 43.52% | -14.66% | 104.43% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,942.41% | -32.74% | -- | -- | 185.17% |
| Cash from Investing | -2,942.41% | -32.74% | -- | -- | 160.70% |
| Total Debt Issued | 122.27% | -98.99% | -- | 526.34% | 63.05% |
| Total Debt Repaid | -87.44% | -- | -- | 5.09% | -- |
| Issuance of Common Stock | 70.92% | 1,456.34% | -- | -- | -26.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 78.76% | -92.44% | -100.00% | -100.00% |
| Cash from Financing | 1,491.15% | 140.25% | -53.60% | 1,414.32% | -104.91% |
| Foreign Exchange rate Adjustments | 1,423.53% | -837.04% | 126.05% | 103.67% | -97.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -920.66% | 278.04% | -80.28% | 123.23% | -92.84% |